Precision Medicine Strategies for Neurological and Kidney Diseases
DOI:
https://doi.org/10.5281/zenodo.22111613Keywords:
BioGenomic Precision Medicine, Genomic Clinical Integration, Neurodevelopmental Disorders, Kidney Disease Genomics, Precision Therapeutics, Cross-Disciplinary Clinical Management, Multi-Organ Dysfunction, Patient Stratification, Genotype–Phenotype Correlation, Translational Genomics, Biomarker Discovery, Therapeutic Target Identification, Population-Level Precision Medicine, Genomic Counseling, Treatment Modulation Strategies, Secondary Prevention, Integrated Genomic Frameworks, Clinical Decision Support, Systems Precision Medicine.Abstract
BioGenomic Precision Medicine (BP Med), encompassing genomic developments from technology to clinical integration, offers a distinctive perspective on precision medicine in neuro and kidney disorders. In addition to an overview of BP Med, areas of neuro and kidney diseases for which genomic studies have provided insights into therapeutic strategies are considered, as well as cross-disciplinary clinical management of conditions with both neurodevelopmental and kidney features.
Traditionally, precision medicine has focused on targeted therapies for small patient subsets sharing a disorder-associated mutation, epigenetic alteration, or biomarker. BP Med expands this logic from narrow disease targets to include broader and potentially more impactful insights by addressing foundational concepts and resources for the implementation of precision medicine, thereby indirectly enabling stratification of the entire affected population or improving response profiles for all patients, whether by counselling, treatment modulation in multi-organ dysfunctions, or secondary preventive strategies. BP Med invites integration of established but previously compartmentalized genomic knowledge into a more comprehensive and clinically useful frame. Without such inclusion, especially in the neurodevelopmental field, replication may remain elusive, independent comparisons across specialties may lack value, and resolution of plot holes may remain unfulfilled.
References
1. de Boer, I. H., Alpers, C. E., Azeloglu, E. U., Balis, U. G. J., Barasch, J. M., Barisoni, L., Blank, K. N., Bomback, A. S., Brown, K., Dagher, P. C., Dighe, A. S., Eadon, M. T., El-Achkar, T. M., Gaut, J. P., Hacohen, N., He, Y., Hodgin, J. B., Jain, S., Kellum, J. A., ... Himmelfarb, J. (2021). Rationale and design of the Kidney Precision Medicine Project. Kidney International, 99(3), 498–510.
2. Meschia, J. F., & Dichgans, M. (2021). Genetics, genomics, and precision medicine. Stroke, 52(10), 3385–3387.
3. Davuluri, P. S. L. (2023). AI-Augmented Sanctions Screening: Enhancing Accuracy and Latency in Real Time Compliance Systems. AI-Augmented Sanctions Screening: Enhancing Accuracy and Latency in Real Time Compliance Systems (December 15, 2023).
4. Mallett, A. J., Knoers, N., Sayer, J., & Stark, Z. (2021). Clinical versus research genomics in kidney disease. Nature Reviews Nephrology, 17, 570–571.
5. Kim, J., & Park, J. (2021). Single-cell transcriptomics: A novel precision medicine technique in nephrology. Korean Journal of Internal Medicine, 36(3), 479–490.
6. Inala, R., & Somu, B. (2024). Agentic ai in retail banking: Redefining customer service and financial decision-making. Journal of Artificial Intelligence and Big Data Disciplines, 1(1), 1-19.
7. Domingo-Gallego, A., Pybus, M., Bullich, G., Furlano, M., Ejarque-Vila, L., Lorente-Grandoso, L., Ruiz, P., Fraga, G., López González, M., Piñero-Fernández, J. A., Rodríguez-Peña, L., Llano-Rivas, I., Sáez, R., Bujons-Tur, A., Ariceta, G., Guirado, L., Torra, R., & Ars, E. (2022). Clinical utility of genetic testing in early-onset kidney disease: Seven genes are the main players. Nephrology Dialysis Transplantation, 37(4), 687–696.
8. Hay, E., Cullup, T., & Barnicoat, A. (2022). A practical approach to the genomics of kidney disorders. Pediatric Nephrology, 37(1), 21–35.
9. FitzPatrick, L., & Bird, A. (2021). Genetic therapies for neurological disorders. Human Genetics, 141, 1–18.
10. Ahmed, Z. (2022). Precision medicine with multi-omics strategies, deep phenotyping, and predictive analysis. Progress in Molecular Biology and Translational Science, 190(1), 101–125.
11. Inala, R. (2023). AI-powered investment decision support systems: Building smart data products with embedded governance controls. Journal for ReAttach Therapy and Developmental Diversities, 6(10), 2251-2266.
12. McGinn, R. J., Von Stein, E. L., Summers Stromberg, J. E., & Li, Y. (2022). Precision medicine in epilepsy. Progress in Molecular Biology and Translational Science, 190(1), 147–188.
13. O'Bryant, S. E., Petersen, M., Zhang, F., Johnson, L., Mason, D., & Hall, J. (2022). Analysis of a precision medicine approach to treating Parkinson's disease: Analysis of the DATATOP study. Parkinsonism & Related Disorders, 94, 15–21.
14. Straccia, G., Colucci, F., Eleopra, R., & Cilia, R. (2022). Precision medicine in Parkinson's disease: From genetic risk signals to personalized therapy. Brain Sciences, 12(10), 1308.
15. Kolla, S. K., & Mangalampalli, B. M. (2024). Edge-Based Deep Learning Systems for Point-of-Care Diagnostic Intelligence. Journal of Neonatal Surgery, 13(1), 2387-2399.
16. Sullivan, J., & Wirrell, E. C. (2022). Dravet syndrome as an example of precision medicine in epilepsy. Epilepsy Currents, 23(1), 4–7.
17. Toups, K., Hathaway, A., Gordon, D., Chung, H., Raji, C., Boyd, A., Hill, B. D., Hausman-Cohen, S., Attarha, M., Chwa, W. J., Jarrett, M., & Bredesen, D. E. (2022). Precision medicine approach to Alzheimer's disease: Successful pilot project. Journal of Alzheimer's Disease, 88(4), 1411–1421.
18. Zanoni, F., Khairallah, P., Kiryluk, K., & Batal, I. (2022). Glomerular diseases of the kidney allograft: Toward a precision medicine approach. Seminars in Nephrology, 42(1), 29–43.
19. Inala, R. Designing Scalable Technology Architectures for Customer Data in Group Insurance and Investment Platforms.
20. Bogyo, K., Vena, N., May, H., Milo Rasouly, H., Marasa, M., Sanna-Cherchi, S., Kiryluk, K., Nestor, J., & Gharavi, A. G. (2022). Incorporating genetics services into adult kidney disease care. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 190(3), 289–301.
21. Elliott, M. D., Milo Rasouly, H., & Gharavi, A. G. (2023). Genetics of kidney disease: The unexpected role of rare disorders. Annual Review of Medicine, 74, 353–367.
22. Mühlig, A. K., Oh, J., & Huber, T. B. (2023). Precision nephrology: From molecular diagnostics to an individualized therapy. Kidney International, 103(3), 464–466.
23. Jayaraman, P., Crouse, A., & Nadkarni, G. N. (2023). A primer in precision nephrology: Optimizing outcomes in kidney health and disease through data-driven medicine. Kidney360, 4(4), e544–e554.
24. Pandey, A. K., & Loscalzo, J. (2023). Network medicine: An approach to complex kidney disease phenotypes. Nature Reviews Nephrology, 19, 463–475.
25. Kolla, S. K., & Reddy, V. A. R. (2024). Evaluating Cloud-Native vs. Hybrid Architectures for Health Benefit Administration Systems. International Journal of Medical Toxicology and Legal Medicine, 27(5), 1042-1053.
26. Sanmarchi, F., Fanconi, C., Golinelli, D., Gori, D., Hernandez-Boussard, T., & Capodici, A. (2023). Predict, diagnose, and treat chronic kidney disease with machine learning: A systematic literature review. Journal of Nephrology, 36(4), 1101–1117.
27. Zhu, J., Lu, J., & Weng, H. (2023). Single-cell RNA sequencing for the study of kidney disease. Cellular & Molecular Biology Letters, 29(1), 85.
28. Hampel, H., Gao, P., Cummings, J., & colleagues. (2023). The foundation and architecture of precision medicine in neurology and psychiatry. Trends in Neurosciences, 46(3), 176–198.
29. Gottimukkala, V. R. R. (2024). Federated Learning Approaches for Fraud Detection in International Payment Systems. https://www. jisem-journal. com/download/118_JISEM. pdf.
30. Papadopoulou, E., Pepe, G., Konitsiotis, S., Chondrogiorgi, M., Grigoriadis, N., Kimiskidis, V. K., Tsivgoulis, G., Mitsikostas, D. D., Chroni, E., Domouzoglou, E., Tsaousis, G., & Nasioulas, G. (2023). The evolution of comprehensive genetic analysis in neurology: Implications for precision medicine. Journal of the Neurological Sciences, 447, 120609.
31. Tate, A., Suárez-Calvet, M., Ekelund, M., Eriksson, S., Eriksdotter, M., Van Der Flier, W. M., Georges, J., Kivipelto, M., Kramberger, M. G., Lindgren, P., López, J. D. G., Lötjönen, J., Persson, S., Pla, S., Solomon, A., Thurfjell, L., Wimo, A., Winblad, B., & Jönsson, L. (2023). Precision medicine in neurodegeneration: The IHI-PROMINENT project. Frontiers in Neurology, 14, 1175922.
32. Balestrini, S., Mei, D., Sisodiya, S. M., & Guerrini, R. (2023). Steps to improve precision medicine in epilepsy. Drugs & Therapy Perspectives, 27(6), 661–672.
33. El-Achkar, T. M., Eadon, M. T., Kretzler, M., Himmelfarb, J., & Kidney Precision Medicine Project. (2024). Precision medicine in nephrology: An integrative framework of multidimensional data in the Kidney Precision Medicine Project. American Journal of Kidney Diseases, 83(3), 402–410.
34. Kolla, T. (2024). Graph Neural Networks for HCC Risk Adjustment and Interoperability. International Journal of Science, Research and Technology, 7(6), 13244-13255.
35. Zhang, J., Zeng, W., Hamrahian, S., & Maarouf, O. H. (2024). Incorporating genetic testing into a routine kidney clinic. Clinical Nephrology, 102, 25–31.
36. De Wachter, M., Schoonjans, A.-S., Weckhuysen, S., Van Schil, K., Löfgren, A., Meuwissen, M., Jansen, A., & Ceulemans, B. (2024). From diagnosis to treatment in genetic epilepsies: Implementation of precision medicine in real-world clinical practice. European Journal of Paediatric Neurology, 48, 46–60.
37. Marras, C., Fereshtehnejad, S.-M., Berg, D., Bohnen, N. I., Dujardin, K., Erro, R., Espay, A. J., Halliday, G., Van Hilten, J. J., Hu, M. T., Jeon, B., Klein, C., Leentjens, A. F. G., Mollenhauer, B., Postuma, R. B., Rodríguez-Violante, M., Simuni, T., Weintraub, D., Lawton, M., & Mestre, T. A. (2024). Transitioning from subtyping to precision medicine in Parkinson's disease: A purpose-driven approach. Movement Disorders, 39(3), 462–471.
38. Fatima, A., & Masood, S. (2024). Machine learning approaches for neurological disease prediction: A systematic review. Expert Systems, 41(9), e13569.
Additional Files
Published
Data Availability Statement
none
Issue
Section
License
Copyright (c) 2024 Pierre Moreau (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons
Attribution 4.0 International License (CC BY 4.0).
You are free to:
- Share: copy and redistribute the material
- Adapt: remix, transform, and build upon the material
for any purpose, even commercially.
Under the following terms:
Attribution — You must give appropriate credit to
the original author(s) and source.
Full license text: https://creativecommons.org/licenses/by/4.0/
